Using Retinal Imaging to Predict Cardiovascular Disease and Atherosclerosis Risk
For decades, physicians have viewed the eye as a window into the body’s overall health. While traditionally used to diagnose vision loss, new advancements in retinal imaging are transforming the eye into a powerful noninvasive tool for predicting latent atherosclerosis and cardiovascular disease (CVD). By analyzing the microvascular changes in the retina, clinicians can now identify markers of systemic vascular risk before a major cardiac event occurs.
- Retinal imaging modalities like OCT and OCTA can detect subclinical atherosclerosis.
- Reduced retinal vascular density is associated with subclinical coronary atherosclerosis in asymptomatic individuals.
- Retinal alterations can reflect both microvascular and macrovascular changes, making them useful biomarkers for ASCVD risk.
- Imaging techniques provide objective, accessible data for cardiovascular risk stratification.
The Role of Retinal Imaging in Cardiovascular Risk Stratification
Cardiovascular disease remains a leading cause of preventable morbidity and mortality worldwide. To combat this, researchers are exploring noninvasive tools to predict “latent” atherosclerosis—plaque buildup in the arteries that hasn’t yet caused symptoms. Retinal imaging, including fundoscopy, optical coherence tomography (OCT), and optical coherence tomography angiography (OCTA), has emerged as a promising frontier for CVD prognostication.
These tools allow doctors to observe the blood vessels of the retina, which are the only place in the human body where the microvasculature can be visualized directly and noninvasively. Because the retinal vessels share similar structural and functional characteristics with the vessels in the heart and brain, changes in the eye often mirror systemic vascular decay.
Advanced Imaging Technologies: OCT and OCTA
While traditional fundoscopy provides a basic view, newer technologies offer a deeper, more quantitative analysis of vascular health.
Optical Coherence Tomography (OCT)
OCT measurements of different retinal layers and specific findings, such as retinal ischemic perivascular lesions, serve as objective biomarkers for incipient CVD. These measurements aid clinicians identify risk factors early in the disease progression.
Optical Coherence Tomography Angiography (OCTA)
OCTA provides a detailed map of blood flow without the need for injectable dyes. Recent research highlights several critical metrics that can inform a patient’s cardiovascular risk:
- Retinal Vessel Density (VD): A reduction in vascular density has been linked to subclinical coronary atherosclerosis in people without symptoms.
- Foveal Avascular Zone (FAZ): Changes in the area and perimeter of the FAZ, as well as the vessel density within the ring surrounding it, are being studied as indicators of atherosclerotic cardiovascular disease (ASCVD) risk.
- Retinal Nerve Fiber Layer (RNFL): Thickness measurements of the RNFL are used alongside vascular density to assess overall retinal health and its correlation with systemic disease.
Application in High-Risk Populations
The utility of these imaging tools is particularly evident in patients with dyslipidemia. A recent study involving 261 patients with dyslipidemia used OCTA to evaluate retinal vascular changes as potential biomarkers for ASCVD risk assessment. By analyzing the macula and optic disc, researchers aimed to distinguish between those with and without ASCVD, demonstrating that retinal alterations can reflect macrovascular changes throughout the body.
Comparing Retinal Imaging Modalities
| Modality | Primary Use | CVD Insight |
|---|---|---|
| Fundoscopy | Visual inspection of the retina | Detection of discrete vascular conditions |
| OCT | Cross-sectional layer imaging | Layer thickness and ischemic lesions |
| OCTA | Blood flow mapping | Vessel density and FAZ alterations |
Frequently Asked Questions
Can a retinal scan replace a stress test or angiogram?
No. Retinal imaging is currently used as an adjunct for risk stratification and the detection of subclinical atherosclerosis. It helps identify high-risk patients who may need more intensive monitoring or traditional diagnostic testing.
Who should consider retinal screening for cardiovascular risk?
Individuals with risk factors such as dyslipidemia or those who are asymptomatic but have a family history of heart disease may benefit from these screenings to detect early vascular changes.
Conclusion
The integration of retinal imaging into cardiovascular care represents a shift toward more proactive, noninvasive diagnostics. By leveraging OCT and OCTA to detect reduced vessel density and other microvascular alterations, healthcare providers can better identify patients at risk for ASCVD. As these technologies evolve, the eye will likely play an increasingly central role in the early detection and prevention of global cardiovascular mortality.